These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26137585)

  • 1. MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation.
    Chen TT; Filvaroff E; Peng J; Marsters S; Jubb A; Koeppen H; Merchant M; Ashkenazi A
    EBioMedicine; 2015 May; 2(5):406-20. PubMed ID: 26137585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the IRE1α/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization.
    Liu L; Qi X; Chen Z; Shaw L; Cai J; Smith LH; Grant MB; Boulton ME
    Am J Pathol; 2013 Apr; 182(4):1412-24. PubMed ID: 23395094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival.
    Chabot C; Spring K; Gratton JP; Elchebly M; Royal I
    Mol Cell Biol; 2009 Jan; 29(1):241-53. PubMed ID: 18936167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
    Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
    Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium.
    Dellinger MT; Brekken RA
    PLoS One; 2011; 6(12):e28947. PubMed ID: 22174934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.
    Jamison S; Lin Y; Lin W
    PLoS One; 2015; 10(3):e0120252. PubMed ID: 25794107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
    Wang G; Sun M; Jiang Y; Zhang T; Sun W; Wang H; Yin F; Wang Z; Sang W; Xu J; Mao M; Zuo D; Zhou Z; Wang C; Fu Z; Wang Z; Duan Z; Hua Y; Cai Z
    Int J Cancer; 2019 Aug; 145(4):979-993. PubMed ID: 30719715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melittin protein inhibits the proliferation of MG63 cells by activating inositol-requiring protein-1α and X-box binding protein 1-mediated apoptosis.
    Fan Q; Hu Y; Pang H; Sun J; Wang Z; Li J
    Mol Med Rep; 2014 Apr; 9(4):1365-70. PubMed ID: 24535635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum quality control in cancer: Friend or foe.
    Kim H; Bhattacharya A; Qi L
    Semin Cancer Biol; 2015 Aug; 33():25-33. PubMed ID: 25794824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
    Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
    Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma.
    Zhang Y; Gao X; Zhu Y; Kadel D; Sun H; Chen J; Luo Q; Sun H; Yang L; Yang J; Sheng Y; Zheng Y; Zhu K; Dong Q; Qin L
    J Exp Clin Cancer Res; 2018 Apr; 37(1):93. PubMed ID: 29712569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.